[1]邵雅楠,赵刚.加味玉肾露治疗消渴病肾病气阴两虚兼血瘀证30例临床观察[J].甘肃中医药大学学报,2018,35(05):70-74.[doi:10.16841/j.issn1003-8450.2018.05.16]
 SHAO Ya,ZHAO Gang.Clinical observation on 30 cases of diabetic kidney disease with deficiency of both qi and yin combined blood stasis treated with Jiawei Yushen Lu[J].Journal of Gansu University of Chinese Medicine,2018,35(05):70-74.[doi:10.16841/j.issn1003-8450.2018.05.16]
点击复制

加味玉肾露治疗消渴病肾病气阴两虚兼血瘀证30例临床观察()
分享到:

《甘肃中医药大学学报》[ISSN:1003-8450/CN:62-1062/R]

卷:
35卷
期数:
2018年05期
页码:
70-74
栏目:
临床研究与报道
出版日期:
2018-10-25

文章信息/Info

Title:
Clinical observation on 30 cases of diabetic kidney disease with deficiency of both qi and yin combined blood stasis treated with Jiawei Yushen Lu
作者:
邵雅楠1 赵刚2
1. 辽宁中医药大学第一临床学院, 辽宁 沈阳 110847;
2. 辽宁中医药大学附属医院肾内科, 辽宁 沈阳 110032
Author(s):
SHAO Ya1 ZHAO Gang2
1. The First Clinical College, Liaoning University of TCM, Shenyang, Liaoning, 110847, China;
2. Department of Nephrology, Affiliated Hospital of Liaoning University of TCM, Shenyang, Liaoning, 110032, China
关键词:
消渴病肾病气阴两虚兼血瘀证加味玉肾露蛋白尿临床观察
Keywords:
diabetic kidney disease(DKD)deficiency of both qi and yin combined blood stasisJiawei Yushen Luproteinuriaclinical observation
分类号:
R255.4
DOI:
10.16841/j.issn1003-8450.2018.05.16
摘要:
目的 观察加味玉肾露治疗消渴病肾病(DKD)气阴两虚兼血瘀证的临床疗效。方法 将60例DKD气阴两虚兼血瘀证患者采用随机数字表法分为治疗组与对照组,各30例。2组均给予常规治疗,对照组在常规治疗的基础上给予怡开口服,治疗组在常规治疗的基础上给予加味玉肾露。2组均以4周为1个疗程,连续治疗6个疗程后比较2组治疗前后的血肌酐(Scr)、尿素氮(BUN)、24小时尿蛋白定量(24 h Upro)、糖化血红蛋白(HbA1c)含量及临床疗效。结果 对照组总有效率为56.67%,治疗组为83.33%,2组比较差异有统计学意义(P<0.05);2组治疗后Scr、BUN、24 h Upro及HbA1c含量均显著下降,与同组治疗前比较差异有统计学意义(P<0.05),且治疗组的Scr、BUN、24 h Upro下降更显著,与对照组治疗后比较差异有统计学意义(P<0.05)。结论 加味玉肾露治疗DKD气阴两虚兼血瘀证临床疗效显著,可有效改善患者的实验室指标,值得临床推广应用。
Abstract:
Objective To observe the clinical efficacy of Jiawei Yushen Lu in treating DKD (Diabetic Kidney Disease) with deficiency of both qi and yin combined blood stasis. Methods Sixty cases of DKD with deficiency of both qi and yin combined blood stasis were randomly divided into treatment group and control group,30 cases in each group.The 2 groups were given conventional treatment. Moreover,the control group was treated with YiKai,while the treatment group was treated with Jiawei Yushen Lu. A course of treatment for the 2 groups was 4 weeks. After 6 consecutive courses of treatment,the levels of serum creatinine (Scr),BUN,the 24-hour urine protein quantity (24 h Upro),glycosylated hemoglobin (HbA1c) content and their clinical efficacy in the 2 groups before and after treatment were compared. Results The total effective rate of the control group was 56.67%,that of the treatment group was 83.33%,there was statistical difference between the 2 groups (P<0.05). After treatment,the levels of Scr,BUN,24 h Upro and HbA1c content in the 2 groups reduced significantly (P<0.05),there was statistical difference compared with the same group before treatment. Moreover,the levels of Scr,BUN,24 h Upro and HbA1c content in the treatment group decreased more significantly,there was statistical difference compared with those of the control group after treatment (P<0.05). Conclusion Jiawei Yushen Lu has a remarkable curative effect on the treatment of DKD with deficiency of both qi and yin combined blood stasis,improving patients’ laboratory data,which is worthy of clinical promotion and application.

参考文献/References:

[1] 中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识(2014年版)[J].中华糖尿病杂志,2014,6(11):792-801.
[2] 中华中医药学会.糖尿病肾病中医防治指南[J].中国中医药远程现代教育,2011,9(4):151-153.
[3] Mogensen M D.Microalbuminuria predicts clinica proteinuria and early mortality in maturity-onset diabetes[J].N Engl J Med,1984,310(6):356-360.
[4] 中华中医药学会肾病分会. 糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7.
[5] 朱淑媛,鲍晓荣.糖尿病肾病足细胞自噬异常的机制研究进展[J].中国中西医结合肾病杂志,2017,18(6):561-562.
[6] Na J,Sweetwyne M,Park A S,et al.Diet-Induced podocyte dysfunction in drosophila,and mammals[J].Cell Reports,2015,12(4):636-647.
[7] 周素娴.高糖高脂对肾小球细胞影响的研究进展[J].新医学,2014,45(5):286-289.
[8] 洪金妮,黎巍威,王学美.糖尿病肾病中足细胞损伤的信号通路及中药的干预研究进展[J].中药药理与临床,2017,33(3):215-219.
[9] WANG N,WEI R B,LI Q P,et al.Protective effects of astragaloside in ratswith adriamycin nephropathy and underlying mechanism[J].Chin J Nat Med,2016,14(4):270-277.
[10] 孙兴旺,曹灵,于国华,等.丹参酮ⅡA磺酸钠对纤维化人肾间质成纤维细胞体外增殖及cyclin E蛋白表达的影响[J].第三军医大学学报,2007,29(7):585.
[11] 唐锦辉,占成业.丹参酮ⅡA对大鼠肾间质纤维化的抑制作用[M].内科急危重症杂志,2008,14(1):16-18.
[12] 于俊生,杜雅静,汪慧惠.蝉蜕、僵蚕对系膜增生性肾小球肾炎模型大鼠肾组织Toll样受体4表达的影响[J].中华中医药学刊,2015,33(1):7-9.
[13] 马艳春,周波,宋立群,等.地龙成分及含药血清对人正常肾小球系膜细胞增殖的影响[J].中国临床保健杂志,2010,13(5):493-495.
[14] 徐瑜萍,向铮,潘瑜,等.菟丝子水提物对肾间质纤维化大鼠肾组织保护作用的研究[J].中成药,2013,35(10):2013-2018.
[15] 李菁菁,罗琼,闫俊,等.枸杞多糖对糖尿病肾病兔肾功能及MCP-1ICAM-1mRNA表达的影响[J].营养学报,2015,37(1):32-36.

备注/Memo

备注/Memo:
收稿日期:2018-03-31。
作者简介:邵雅楠(1993-),女,在读硕士研究生。研究方向:中医内科学(肾脏病)。
通信作者:赵刚(1962-),男,主任医师,教授,硕士生导师,医学硕士。研究方向:中医肾内科疾病。E-mail:zhaogang1961@126.com
更新日期/Last Update: 1900-01-01